The European Society for translational Antiviral Research (ESAR) aims to unite scientists and clinicians throughout Europe to expand knowledge on resistant viruses and to investigate the molecular epidemiology of drug-resistant viruses in Europe from Public Health and scientific perspectives.

ESAR will act as a collaborative network for scientific studies, quality control, guidelines and training activities.In particular the society aims to:

• Improving the knowledge of resistant viruses, particularly as it relates to the diagnosis and management of drug resistance, their pathogenesis, natural history of spread and prevention; 

• Improving diagnostic methods;

• Keeping and improving high standards in laboratory diagnosis of resistant viruses through promotion of quality assessment (QA) activities and education;

• Facilitating the exchange of reference reagents;

• Interaction with relevant organisations, such as other virological societies and groups and between members. 

ESAR performs the SPREAD programme in which virological reference centers from over >30 European countries are studying the appearance, spread, virological determinants and clinical consequences of HIV resistance under joint standards linked to a common shared self-sustainable database.

ESAR is the successor of the European Commission supported LSHP-CT-2006-518211 EuropeHIVResistance network. To become a member of ESAR please send send an e-mail to Antoinet van Kessel via info@esar-society.eu.